Danaher Corporation $DHR Stock Purchased by Kestra Advisory Services LLC

Kestra Advisory Services LLC raised its stake in Danaher Corporation (NYSE:DHR) by 4.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 78,390 shares of the conglomerate’s stock after purchasing an additional 3,643 shares during the period. Kestra Advisory Services LLC’s holdings in Danaher were worth $17,367,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of DHR. Claro Advisors Inc. bought a new position in Danaher in the 3rd quarter valued at approximately $301,000. Quadcap Wealth Management LLC boosted its stake in Danaher by 7.8% during the 3rd quarter. Quadcap Wealth Management LLC now owns 1,211 shares of the conglomerate’s stock valued at $268,000 after purchasing an additional 88 shares during the last quarter. Commonwealth Equity Services LLC grew its stake in Danaher by 3.7% in the 3rd quarter. Commonwealth Equity Services LLC now owns 88,507 shares of the conglomerate’s stock valued at $19,609,000 after purchasing an additional 3,119 shares during the period. Collaborative Fund Advisors LLC bought a new stake in Danaher in the 3rd quarter valued at about $548,000. Finally, Chicago Partners Investment Group LLC lifted its holdings in Danaher by 12.3% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 14,943 shares of the conglomerate’s stock worth $3,444,000 after purchasing an additional 1,637 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on DHR shares. Robert W. Baird boosted their target price on Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a research report on Thursday, October 22nd. Wells Fargo & Company lowered their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Royal Bank Of Canada lifted their price target on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. JPMorgan Chase & Co. boosted their price objective on Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. Finally, TD Cowen upped their price objective on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Thursday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $242.91.

Insider Activity at Danaher

In other news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction dated Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the sale, the chief accounting officer directly owned 9,107 shares in the company, valued at approximately $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 10.80% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $230.34 on Monday. The company has a 50-day simple moving average of $220.27 and a two-hundred day simple moving average of $201.60. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a market cap of $162.05 billion, a price-to-earnings ratio of 37.70, a PEG ratio of 2.89 and a beta of 0.76. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $1.92 by $0.19. The firm had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The company’s quarterly revenue was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.89 earnings per share. On average, equities analysts forecast that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher’s dividend payout ratio is 26.19%.

About Danaher

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing.

The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.